Drugs / amoxicillin/clavulanic acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00062231 | Apr 2002 → Oct 2006 | cancer of unknown primary site, infectious disease, leukemia, myelodysplastic syndrome +5 | European Organisation for Research and Treatment of Cancer - EORTC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amoxicillin/clavulanic acid | “Patients received either moxifloxacin (400 mg once daily) monotherapy or oral ciprofloxacin (750 mg twice daily) plus amoxicillin/clavulanic acid (1,000 mg twice daily).” PMID 23358983 ↗ Jan 2013 |
| Route | Oral | “Patients receive oral ciprofloxacin and oral amoxicillin-clavulanate potassium twice daily.” NCT00062231 ↗ |